[Bipolar I disorder].
Kaneko
Naoko
N
Department of Neuropsychiatry, Faculty of Medicine, University of Yamanashi.
Shioe
Kunihiko
K
Kanba
Shigenobu
S
D018692:Antimanic Agents / Q000627:therapeutic use; D015306:Biogenic Monoamines / Q000502:physiology; D001714:Bipolar Disorder / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004565:Electroconvulsive Therapy; D004781:Environmental Exposure; D020022:Genetic Predisposition to Disease; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D011613:Psychotherapy / Q000379:methods; D012008:Recurrence; D012015:Reference Standards; D012307:Risk Factors
D018692:Antimanic Agents; D015306:Biogenic Monoamines; D008094:Lithium